$NRIX News

Nurix Therapeutics, Inc. (NRIX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

BTIG Reiterates Buy on Nurix Therapeutics, Maintains $30 Price Target

A Nurix Therapeutics (NRIX) Insider Sold 5,394 Shares for $90,000

Nurix Therapeutics Inc. (NRIX): Leadership in Targeted Protein Degradation Attracts Smart Money

HC Wainwright & Co. Reiterates Buy on Nurix Therapeutics, Maintains $32 Price Target

Needham Reiterates Buy on Nurix Therapeutics, Maintains $26 Price Target

Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026

Nurix Therapeutics Announced New Preclinical Data From Multiple Oncology Programs At The American Association For Cancer Research Annual Meeting

Wells Fargo Cuts PT on Nurix Therapeutics (NRIX) to $28 From $29

Nurix Therapeutics, Inc. (NRIX) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

Did Sanofi Revenue Expiry and Rising R&D Spend Just Recast Nurix Therapeutics' (NRIX) Investment Narrative?

Does Nurix Therapeutics (NRIX) Have the Potential to Rally 85.84% as Wall Street Analysts Expect?

HC Wainwright & Co. Reiterates Buy on Nurix Therapeutics, Maintains $32 Price Target

Nurix: 'Strong Buy' Bexobruditeg Development And Dual Degrader Zelebrudomide

Wells Fargo Maintains Overweight on Nurix Therapeutics, Lowers Price Target to $28

Needham Reiterates Buy on Nurix Therapeutics, Maintains $26 Price Target

Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

Nurix Therapeutics Q1 EPS $(0.79) Beats $(0.86) Estimate, Sales $6.252M Miss $16.607M Estimate

Nurix Therapeutics to Participate in Upcoming Investor Conference

A Look At Nurix Therapeutics (NRIX) Valuation After Strong 1 Year Return And High Price To Sales Ratio